Cargando…
Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty
OBJECTIVE: Gonadotropin-releasing hormone agonist (GnRHa) treatment improves the potential for gaining height in patients with central precocious puberty (CPP). However, most studies have focused on girls because CPP in boys is relatively rare. Therefore, we aimed to determine the effect of GnRHa tr...
Autores principales: | Shim, Young Suk, Lim, Kyung In, Lee, Hae Sang, Hwang, Jin Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728242/ https://www.ncbi.nlm.nih.gov/pubmed/33301485 http://dx.doi.org/10.1371/journal.pone.0243212 |
Ejemplares similares
-
Changes in body mass index in boys with central precocious puberty over 2 years of gonadotropin-releasing hormone agonist therapy
por: Lim, Kyung In, et al.
Publicado: (2020) -
Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty
por: Kwon, Eun Byul, et al.
Publicado: (2015) -
Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2023) -
Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty
por: Lee, Hae Sang, et al.
Publicado: (2018) -
Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2021)